It is worth noting that from the non-T2D signaling pathway, IL6 was characterized as an anti-inflammatory cytokine and indirectly interacted with ISL1 and SETD7 to activate PDX1, intensifying cell proliferation. The gene discussed is ISL1; the disease is type 2 diabetes mellitus.